TABLE 1.
The list of human brain samples used in our study.
| NIH# | RTT/Control | Age(Years) | Sex | PMD |
| * | T158M | 13 | F | <6 h |
| * | A201V | 19 | F | 24 h |
| 4516 | R255X | 20 | F | 9 h |
| 5401 | Control | 19 | F | 22 h |
| 5646 | Control | 20 | F | 23 h |
| 5287 | Control | 23 | F | 15 h |
| ¤ | Control | 14 | F | 24 h |
| ¤ | Control | 18 | F | 48 h |
All patients and controls are Caucasian. Two RTT brain samples (T158M and A201V) were donated directly to our lab for research (*), and were coordinated through collaboration with Dr. Victoria Siu (Western University) who obtained proper consent for research, as reported previously (Olson et al., 2018; Pejhan et al., 2020). Two control brain samples for Hematoxylin and Eosin (H&E) staining were provided by the Health Sciences Centre Pathology Laboratory, Winnipeg, MB (¤), coordinated by Dr. Marc Del Bigio. Post-mortem delay (PMD) shows the interval between death and tissue preservation. Samples from NIH NeuroBioBank were obtained by Dr. Mojgan Rastegar and signed Material Transfer Agreement (MTA); F (Female).